Showing results (741-750 of 782) with videos related to

Sort By:
Pageof 79
Integrative and Comparative Biology|June 15, 2011
Recent advances in crustacean genomicsJonathon H Stillman, John K Colbourne, Carol E Lee, et al.
Journal of Cataract and Refractive Surgery|June 2, 2021
Risk factors for posterior capsule rupture in cataract surgery as reflected in the European Registry of Quality Outcomes for Cataract and Refractive SurgeryMaartje H M Segers, Anders Behndig, Frank J H M van den Biggelaar, et al.
Journal of Cataract and Refractive Surgery|February 18, 2022
Outcomes of cataract surgery complicated by posterior capsule rupture in the European Registry of Quality Outcomes for Cataract and Refractive SurgeryMaartje H M Segers, Anders Behndig, Frank J H M van den Biggelaar, et al.
Journal of Cataract and Refractive Surgery|November 30, 2022
Anesthesia techniques and the risk of complications as reflected in the European Registry of Quality Outcomes for Cataract and Refractive SurgeryMaartje H M Segers, Paul Rosen, Frank J H M van den Biggelaar, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 31, 2018
Investigation into the Mechanism(s) That Leads to Platelet Decreases in Cynomolgus Monkeys During Administration of ISIS 104838, a 2'-MOE-Modified Antisense OligonucleotidePadmakumar Narayanan, Lijiang Shen, Brian R Curtis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 1, 2016
Integrated Safety Assessment of 2'-O-Methoxyethyl Chimeric Antisense Oligonucleotides in NonHuman Primates and Healthy Human VolunteersStanley T Crooke, Brenda F Baker, T Jesse Kwoh, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 15, 2015
A single-blind, randomised controlled trial on the effects of lithium and quetiapine monotherapy on the trajectory of cognitive functioning in first episode mania: A 12-month follow-up studyR Daglas, S M Cotton, K Allott, et al.
Nucleic Acid Therapeutics|September 30, 2022
Assessment of the Immunogenicity Potential for Oligonucleotide-Based DrugsScott P Henry, Cecilia Arfvidsson, Josh Arrington, et al.
Pageof 79